BioVariance

Data-driven diagnostics

[BioVariance @biovariance]

Am vergangenen Freitag feierten wir den Umzug in unsere neu ausgebauten Räumlichkeiten in der Kornbühlstraße 28 in Tirschenreuth. 🥳

[BioVariance @biovariance]

https://t.co/2L1Hocqq3v

[BioVariance @biovariance]

Our managing director #DrJosefScheiber was once again active as a #CoAutor for the article #Omicsandartificialintelligenceinkidneydiseases

https://t.co/7pLrij7DV2

[BioVariance @biovariance]

The county of Tirschenreuth finally reached an incidence of 0, and we made a valuable contribution to this. 💪 Gain a deeper insight into our daily #lab work with #PCR in our new blog entry.
#COVID19 @LandkreisTIR

https://t.co/tpOmeBhwkJ

[BioVariance @biovariance]

BioVariance ranks in the TOP 100 most innovative medium-sized companies in Germany 2021! This award is a great honour for us and encourages us to keep breaking new grounds.
#top100 #innovation #award

https://t.co/5nbGspVl4Y

[Jon Trickett MP @jon_trickett]

Breaking News:

Children infected with Coronavirus now filling hospital wards.

This is a very very serious and very worrying escalation. The government must close schools now.

https://t.co/CGkTVTdAAb

[Revert_EU @Revert_EU]

“Designing an Optimal Colorectal Cancer Screening Process in Europe”: The #ThematicNetwork2020 on #colorectalcancer (#CRC) Screening led by the @dice_europe

More info👉https://t.co/IfbKef8vJu

@EU_Commission
@EU_H2020

[BioVariance @biovariance]

SARS‐CoV‐2 infections in cancer outpatients—Most infected patients are asymptomatic carriers without impact on chemotherapy https://t.co/gvSHda5uRa

With a little contribution from our side. Thanks a lot for the good collaboration!

[Revert_EU @Revert_EU]

Published by the @CancerLeagues the Europe’s #BeatingCancerPlan - Position Paper 2020

Full article here👉https://t.co/SNsxVNz4Je

#europeanproject #revert #colorectalcancer #CRC #mCRC #H2020 #artificialintelligence #AI

@EU_H2020

[Revert_EU @Revert_EU]

Check out the interview with Fiorella Guadagni from the #IRCCS @SanRaffaelespa - Coordinator of the @Revert_EU project
For more: https://t.co/ClYLCOYnqy

#europeanproject #revert #colorectalcancer #CRC #mCRC #H2020 #artificialintelligence #AI

@EU_H2020 @promisalute

[BioVariance @biovariance]

Rare SARS-CoV-2 antibody development in cancer patients https://t.co/2pC05x7W6O

[DxPx Conference @DxPx_Conference]

The number of participants is arising! Proud to annouce that @biovariance will also attend the #DxPx Conference on November 17th!

Great to have you on board!

Haven't registered yet? Then visit our website and get convinced by this year's benefits https://t.co/gNdoSjsFEH

[Revert_EU @Revert_EU]

Launch of the EU @Revert_EU project - Targeted Therapy for Cororectal Cancer Patients

For more: https://t.co/4N8hZaxGdT

#europeanproject #revert #colorectalcancer #CRC #mCRC #H2020 #artificialintelligence #AI

@IBBLuxembourg @unifi @promisalute

[BioVariance @biovariance]

Quelle ist Harvard-Professor.

[David Sinclair @davidasinclair]

In 2015, @Baric_Lab wrote: #coronaviruses with bat spike proteins replicate efficiently in human airway cells & achieve [levels] similar to epidemic strains. Vaccines failed to protect mice, [emphasizing] continued risk of reemergence from bats. Called it. https://t.co/LpKclf1ZWD

[David Sinclair @davidasinclair]

Since my Harvard lab closed yesterday, I've been reading and interpreting this week's published papers on #COVID19. What follows is a thread of information, my interpretation, links to sources & predictions. Let's start with what you need to know... #coronavirus #COVIDー19

[BioVariance @biovariance]

#fxh2019 Data in Healthcare is a national resource! Very true

[BioVariance @biovariance]

#fxh2019 In Estonia the state is by law not allowed to ask Healthcare questions twice as it should already know then. Imagine that in Germany 🙊

[BioVariance @biovariance]

@th_rudolf Um des Teufels Advokaten zu spielen: Wo hilft denn Datenschutz bei Gesundheitsdaten wirklich? Natürlich ist das bei Name/Adresse wichtig, bei anonymsierten Verlaufsdaten melde ich aber signifikante Zweifel an. Da würde ein opt-out-Modell wie bei Organspende geplant besser passen!

[BioVariance @biovariance]

@felciano Thanks a lot for following! Let us know if we can help somehow somewhere :-)